STAT3 and neoplasm: In the present study, we show that FAK inhibitors stimulate AKT2S128/CCTαS315/319/323-positive CAFs subset to secrete PCs, which induce malignant cells STAT3 activation to facilitate the therapeutic resistance of tumor cells.